| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 1.10e-10 | 17 | 94 | 6 | GO:0005132 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51A4 OR2M4 OR51A2 TAS2R14 ADRB1 OR2M7 OR2M2 GPR61 SLC39A9 LPAR6 CCR9 OR52H1 OR6C74 GPR82 GPR78 OR2AG2 GPR63 GABBR2 OR51V1 OR2L13 OR2AE1 | 6.49e-10 | 884 | 94 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51A4 OR2M4 OR51A2 TAS2R14 ADRB1 OR2M7 OR2M2 GPR61 SLC39A9 LPAR6 CCR9 OR52H1 OR6C74 GPR82 GPR78 OR2AG2 GPR63 CHRNA10 GABBR2 OR51V1 OR2L13 OR2AE1 PLXNB1 | 5.02e-08 | 1353 | 94 | 23 | GO:0004888 |
| GeneOntologyMolecularFunction | cytokine activity | CXCL13 NDP CCL26 IFNA4 IFNA7 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 2.84e-07 | 250 | 94 | 10 | GO:0005125 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51A4 OR2M4 OR51A2 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 5.76e-06 | 431 | 94 | 11 | GO:0004984 |
| GeneOntologyMolecularFunction | cytokine receptor binding | 2.21e-05 | 324 | 94 | 9 | GO:0005126 | |
| GeneOntologyMolecularFunction | receptor ligand activity | CSPG5 CXCL13 NDP CCL26 IFNA4 IFNA7 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 5.22e-05 | 547 | 94 | 11 | GO:0048018 |
| GeneOntologyMolecularFunction | signaling receptor activator activity | CSPG5 CXCL13 NDP CCL26 IFNA4 IFNA7 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 5.85e-05 | 554 | 94 | 11 | GO:0030546 |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | CSPG5 CXCL13 NDP CCL26 IFNA4 IFNA7 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 1.49e-04 | 616 | 94 | 11 | GO:0030545 |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 4.53e-04 | 7 | 94 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1E SLC5A10 ABCA5 SLC39A9 CYB561D2 TMEM175 OTOP2 PEX6 SLC9B1P1 CACNA1H CHRNA10 SLC30A4 SLC7A11 ABCG8 SLC5A3 | 9.72e-04 | 1289 | 94 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1E SLC5A10 ABCA5 SLC39A9 CYB561D2 TMEM175 OTOP2 SLC9B1P1 CACNA1H CHRNA10 SLC30A4 SLC7A11 ABCG8 SLC5A3 | 1.21e-03 | 1180 | 94 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E SLC5A10 SLC39A9 TMEM175 CACNA1H CHRNA10 SLC30A4 SLC5A3 | 1.58e-03 | 465 | 94 | 8 | GO:0046873 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC5A10 ABCA5 CYB561D2 SLC9B1P1 SLC30A4 SLC7A11 ABCG8 SLC5A3 | 1.85e-03 | 477 | 94 | 8 | GO:0022804 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.92e-03 | 14 | 94 | 2 | GO:0008331 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 3.91e-10 | 21 | 94 | 6 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 9.60e-10 | 24 | 94 | 6 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 2.65e-09 | 28 | 94 | 6 | GO:0042501 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 3.50e-08 | 42 | 94 | 6 | GO:0002323 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51A4 OR2M4 OR51A2 TAS2R14 ADRB1 OR2M7 OR2M2 GPR61 SLC39A9 LPAR6 CCR9 OR52H1 OR6C74 GPR82 GPR78 CXCL13 OR2AG2 GPR63 GABBR2 OR51V1 CCL26 OR2L13 OR2AE1 | 4.87e-08 | 1395 | 94 | 23 | GO:0007186 |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.85e-07 | 55 | 94 | 6 | GO:0043330 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 3.84e-07 | 148 | 94 | 8 | GO:0002286 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 4.20e-07 | 63 | 94 | 6 | GO:0043331 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 4.20e-07 | 63 | 94 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 1.59e-06 | 124 | 94 | 7 | GO:0030101 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 1.59e-06 | 124 | 94 | 7 | GO:0042100 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 1.68e-06 | 125 | 94 | 7 | GO:0046425 | |
| GeneOntologyBiologicalProcess | humoral immune response | CXCL13 DEFB126 CCL26 WFDC12 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 | 2.06e-06 | 321 | 94 | 10 | GO:0006959 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51A4 OR2M4 OR51A2 TAS2R14 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 2.08e-06 | 485 | 94 | 12 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51A4 OR2M4 OR51A2 TAS2R14 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 CHRNA10 OR51V1 OR2L13 OR2AE1 | 2.34e-06 | 582 | 94 | 13 | GO:0050906 |
| GeneOntologyBiologicalProcess | defense response to bacterium | HTN1 HTN3 CXCL13 DEFB126 WFDC12 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 | 2.34e-06 | 405 | 94 | 11 | GO:0042742 |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 2.50e-06 | 85 | 94 | 6 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 2.67e-06 | 86 | 94 | 6 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 3.49e-06 | 90 | 94 | 6 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 3.49e-06 | 90 | 94 | 6 | GO:0050688 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 3.97e-06 | 92 | 94 | 6 | GO:0034340 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 4.11e-06 | 143 | 94 | 7 | GO:1904892 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51A4 OR2M4 OR51A2 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 4.34e-06 | 432 | 94 | 11 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51A4 OR2M4 OR51A2 TAS2R14 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 4.59e-06 | 524 | 94 | 12 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception | OR51A4 OR2M4 OR51A2 CACNA1E TAS2R14 OR2M7 OR2M2 OR52H1 HPS1 OR6C74 OR2AG2 NDP CHRNA10 OR51V1 OR2L13 OR2AE1 LARGE1 | 6.17e-06 | 1072 | 94 | 17 | GO:0007600 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 6.82e-06 | 101 | 94 | 6 | GO:0033138 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51A4 OR2M4 OR51A2 TAS2R14 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 7.10e-06 | 547 | 94 | 12 | GO:0007606 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51A4 OR2M4 OR51A2 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 8.71e-06 | 465 | 94 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 1.24e-05 | 112 | 94 | 6 | GO:0140888 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 1.94e-05 | 251 | 94 | 8 | GO:0002285 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51A4 OR2M4 OR51A2 TAS2R14 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 CHRNA10 OR51V1 OR2L13 OR2AE1 | 2.35e-05 | 722 | 94 | 13 | GO:0051606 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 3.42e-05 | 198 | 94 | 7 | GO:0007259 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 3.76e-05 | 201 | 94 | 7 | GO:0030183 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 3.88e-05 | 137 | 94 | 6 | GO:0033135 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 5.93e-05 | 216 | 94 | 7 | GO:0097696 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | MTOR CCR9 NDP IFNA4 IFNA7 IFNA10 IFNA16 IL9 IFNA17 IFNA21 LARGE1 | 1.57e-04 | 640 | 94 | 11 | GO:1903131 |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | 2.45e-04 | 361 | 94 | 8 | GO:0002366 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | 2.64e-04 | 365 | 94 | 8 | GO:0002263 | |
| GeneOntologyBiologicalProcess | positive regulation of wound healing, spreading of epidermal cells | 3.05e-04 | 6 | 94 | 2 | GO:1903691 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 5.12e-04 | 307 | 94 | 7 | GO:0018105 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 6.42e-04 | 319 | 94 | 7 | GO:0018209 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1E SLC5A10 ADRB1 SLC39A9 MTOR TMEM175 OTOP2 SLC9B1P1 CACNA1H CHRNA10 SLC30A4 SLC5A3 LARGE1 | 6.96e-04 | 1017 | 94 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 7.68e-04 | 537 | 94 | 9 | GO:0030098 | |
| GeneOntologyBiologicalProcess | response to bacterium | UGT1A1 HTN1 HTN3 CXCL13 DEFB126 WFDC12 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 | 9.17e-04 | 916 | 94 | 12 | GO:0009617 |
| GeneOntologyBiologicalProcess | leukocyte differentiation | MTOR CCR9 NDP IFNA4 IFNA7 IFNA10 IFNA16 IL9 IFNA17 IFNA21 LARGE1 | 9.18e-04 | 789 | 94 | 11 | GO:0002521 |
| GeneOntologyBiologicalProcess | B cell activation | 9.49e-04 | 341 | 94 | 7 | GO:0042113 | |
| GeneOntologyBiologicalProcess | defense response to virus | 9.66e-04 | 342 | 94 | 7 | GO:0051607 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1E SLC5A10 ADRB1 SLC39A9 TMEM175 OTOP2 SLC9B1P1 CACNA1H CHRNA10 SLC30A4 SLC5A3 LARGE1 | 9.70e-04 | 922 | 94 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | leukocyte proliferation | 9.72e-04 | 445 | 94 | 8 | GO:0070661 | |
| GeneOntologyBiologicalProcess | regulation of wound healing, spreading of epidermal cells | 1.10e-03 | 11 | 94 | 2 | GO:1903689 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1E SLC5A10 ADRB1 SLC39A9 TMEM175 OTOP2 SLC9B1P1 CACNA1H CHRNA10 SLC30A4 SLC5A3 LARGE1 | 1.17e-03 | 942 | 94 | 12 | GO:0098655 |
| Domain | Interferon_alpha/beta/delta | 1.34e-10 | 17 | 91 | 6 | IPR000471 | |
| Domain | Interferon | 1.34e-10 | 17 | 91 | 6 | PF00143 | |
| Domain | IFabd | 1.34e-10 | 17 | 91 | 6 | SM00076 | |
| Domain | INTERFERON_A_B_D | 1.34e-10 | 17 | 91 | 6 | PS00252 | |
| Domain | GPCR_Rhodpsn_7TM | OR51A4 OR2M4 OR51A2 ADRB1 OR2M7 OR2M2 GPR61 LPAR6 CCR9 OR52H1 OR6C74 GPR82 GPR78 OR2AG2 GPR63 OR51V1 OR2L13 OR2AE1 | 3.15e-09 | 670 | 91 | 18 | IPR017452 |
| Domain | 7tm_1 | OR51A4 OR2M4 OR51A2 ADRB1 OR2M7 OR2M2 GPR61 LPAR6 CCR9 OR52H1 OR6C74 GPR82 GPR78 OR2AG2 GPR63 OR51V1 OR2L13 OR2AE1 | 3.71e-09 | 677 | 91 | 18 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51A4 OR2M4 OR51A2 ADRB1 OR2M7 OR2M2 GPR61 LPAR6 CCR9 OR52H1 OR6C74 GPR82 GPR78 OR2AG2 GPR63 OR51V1 OR2L13 OR2AE1 | 4.46e-09 | 685 | 91 | 18 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51A4 OR2M4 OR51A2 ADRB1 OR2M7 OR2M2 GPR61 LPAR6 CCR9 OR52H1 OR6C74 GPR82 GPR78 OR2AG2 GPR63 OR51V1 OR2L13 OR2AE1 | 5.10e-09 | 691 | 91 | 18 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51A4 OR2M4 OR51A2 ADRB1 OR2M7 OR2M2 GPR61 LPAR6 CCR9 OR52H1 OR6C74 GPR82 GPR78 OR2AG2 GPR63 OR51V1 OR2L13 OR2AE1 | 5.22e-09 | 692 | 91 | 18 | IPR000276 |
| Domain | - | 1.51e-07 | 50 | 91 | 6 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.71e-07 | 51 | 91 | 6 | IPR012351 | |
| Domain | 4_helix_cytokine-like_core | 1.61e-06 | 74 | 91 | 6 | IPR009079 | |
| Domain | Olfact_rcpt | OR51A4 OR2M4 OR51A2 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 3.26e-06 | 393 | 91 | 11 | IPR000725 |
| Domain | Histatin/statherin | 7.02e-05 | 3 | 91 | 2 | IPR030773 | |
| Domain | 7TM_GPCR_Srsx | 2.19e-04 | 112 | 91 | 5 | SM01381 | |
| Domain | Na/solute_symporter_CS | 6.45e-04 | 8 | 91 | 2 | IPR018212 | |
| Domain | VDCCAlpha1 | 1.03e-03 | 10 | 91 | 2 | IPR002077 | |
| Domain | NA_SOLUT_SYMP_2 | 1.50e-03 | 12 | 91 | 2 | PS00457 | |
| Domain | SSF | 1.50e-03 | 12 | 91 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 1.50e-03 | 12 | 91 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 1.50e-03 | 12 | 91 | 2 | PS50283 | |
| Domain | AAA+_ATPase | 5.39e-03 | 144 | 91 | 4 | IPR003593 | |
| Domain | AAA | 5.39e-03 | 144 | 91 | 4 | SM00382 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 6.61e-11 | 28 | 71 | 7 | MM1378 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 1.56e-10 | 17 | 71 | 6 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 2.33e-10 | 18 | 71 | 6 | M47539 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 3.39e-10 | 19 | 71 | 6 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 3.39e-10 | 19 | 71 | 6 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 4.82e-10 | 20 | 71 | 6 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 6.73e-10 | 21 | 71 | 6 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 9.21e-10 | 22 | 71 | 6 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 9.21e-10 | 22 | 71 | 6 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 1.24e-09 | 23 | 71 | 6 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.24e-09 | 23 | 71 | 6 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 1.65e-09 | 24 | 71 | 6 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 1.65e-09 | 24 | 71 | 6 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.65e-09 | 24 | 71 | 6 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 2.80e-09 | 26 | 71 | 6 | M982 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 7.10e-09 | 30 | 71 | 6 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 8.77e-09 | 31 | 71 | 6 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 8.77e-09 | 31 | 71 | 6 | M47964 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 1.02e-08 | 55 | 71 | 7 | M11844 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.31e-08 | 33 | 71 | 6 | MM1379 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 1.37e-08 | 127 | 71 | 9 | M42533 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.58e-08 | 34 | 71 | 6 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.90e-08 | 35 | 71 | 6 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 1.90e-08 | 35 | 71 | 6 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 2.70e-08 | 37 | 71 | 6 | M39785 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 3.77e-08 | 39 | 71 | 6 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 5.15e-08 | 41 | 71 | 6 | MM1493 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 7.60e-08 | 73 | 71 | 7 | M39837 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 2.23e-07 | 52 | 71 | 6 | M13103 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 2.58e-07 | 87 | 71 | 7 | MM15915 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | CCR9 CXCL13 CCL26 IFNA4 IFNA7 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 7.57e-07 | 264 | 71 | 10 | M9809 |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 8.60e-07 | 65 | 71 | 6 | M272 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.46e-06 | 71 | 71 | 6 | M15913 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.54e-06 | 78 | 71 | 6 | M973 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 3.41e-06 | 82 | 71 | 6 | M1002 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51A4 OR2M4 OR51A2 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 3.55e-06 | 389 | 71 | 11 | M14091 |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 5.15e-06 | 88 | 71 | 6 | M16004 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51A4 OR2M4 OR51A2 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 OR51V1 OR2L13 OR2AE1 | 6.90e-06 | 417 | 71 | 11 | M4072 |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 9.62e-06 | 98 | 71 | 6 | M48247 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.21e-05 | 102 | 71 | 6 | M3261 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 1.25e-05 | 155 | 71 | 7 | M17411 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 1.28e-05 | 103 | 71 | 6 | M39434 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51A4 OR2M4 OR51A2 TAS2R14 OR2M7 OR2M2 OR52H1 OR6C74 OR2AG2 CHRNA10 OR51V1 OR2L13 OR2AE1 | 1.47e-05 | 636 | 71 | 13 | M41834 |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 3.06e-05 | 120 | 71 | 6 | M48233 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 4.03e-05 | 126 | 71 | 6 | M45009 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 6.18e-05 | 136 | 71 | 6 | M42547 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 6.44e-05 | 137 | 71 | 6 | M5669 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 6.70e-05 | 138 | 71 | 6 | MM15635 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.10e-04 | 151 | 71 | 6 | M39801 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.11e-04 | 170 | 71 | 6 | M941 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.25e-04 | 326 | 71 | 8 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.93e-04 | 339 | 71 | 8 | M39736 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 5.59e-04 | 204 | 71 | 6 | M45011 | |
| Pathway | WP_NRF2_PATHWAY | 7.15e-04 | 141 | 71 | 5 | M39454 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.49e-03 | 273 | 71 | 6 | M983 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 3.24e-03 | 17 | 71 | 2 | MM14552 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 3.63e-03 | 18 | 71 | 2 | M524 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.62e-13 | 11 | 95 | 6 | 8389790 | |
| Pubmed | 1.62e-13 | 11 | 95 | 6 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.62e-13 | 11 | 95 | 6 | 6444699 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.62e-13 | 11 | 95 | 6 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.62e-13 | 11 | 95 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.62e-13 | 11 | 95 | 6 | 15795237 | |
| Pubmed | 1.62e-13 | 11 | 95 | 6 | 9794439 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.62e-13 | 11 | 95 | 6 | 10448195 | |
| Pubmed | 1.62e-13 | 11 | 95 | 6 | 25310498 | ||
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.62e-13 | 11 | 95 | 6 | 19120292 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 16565497 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 22685550 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 3017340 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 3.23e-13 | 12 | 95 | 6 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 3.23e-13 | 12 | 95 | 6 | 33123150 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 3.23e-13 | 12 | 95 | 6 | 8304945 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 11846978 | ||
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 3.23e-13 | 12 | 95 | 6 | 27988795 | |
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 3.23e-13 | 12 | 95 | 6 | 8760352 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 3.23e-13 | 12 | 95 | 6 | 17512142 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 8656058 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 3.23e-13 | 12 | 95 | 6 | 1886773 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 3.23e-13 | 12 | 95 | 6 | 1422836 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 3.23e-13 | 12 | 95 | 6 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 3.23e-13 | 12 | 95 | 6 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 3.23e-13 | 12 | 95 | 6 | 32016282 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 3.23e-13 | 12 | 95 | 6 | 7530016 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 17277125 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 9794206 | ||
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 3.23e-13 | 12 | 95 | 6 | 7684767 | |
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 3.23e-13 | 12 | 95 | 6 | 1360280 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 3.23e-13 | 12 | 95 | 6 | 26277892 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 3.23e-13 | 12 | 95 | 6 | 18716002 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 17451966 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 25897172 | ||
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 3.23e-13 | 12 | 95 | 6 | 16611902 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 30967261 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 3.23e-13 | 12 | 95 | 6 | 8672140 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 3.23e-13 | 12 | 95 | 6 | 22912583 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 23747509 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 17434974 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 3.23e-13 | 12 | 95 | 6 | 3758677 | |
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 7601556 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 19406830 | ||
| Pubmed | 3.23e-13 | 12 | 95 | 6 | 8245849 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 5.98e-13 | 13 | 95 | 6 | 12930842 | |
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 23804712 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 5.98e-13 | 13 | 95 | 6 | 3973562 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 5.98e-13 | 13 | 95 | 6 | 2014240 | |
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 18005734 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 12050368 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 5.98e-13 | 13 | 95 | 6 | 2987810 | |
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 5.98e-13 | 13 | 95 | 6 | 6094686 | |
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 2993652 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 19130550 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 1655578 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 21469099 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 2471809 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 22739040 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 21263073 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 8438572 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 38660315 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 9343822 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 20065291 | ||
| Pubmed | Effects of IFN alpha on late stages of HIV-1 replication cycle. | 5.98e-13 | 13 | 95 | 6 | 9865497 | |
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 9181467 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 5.98e-13 | 13 | 95 | 6 | 23255800 | |
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 17723216 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 7523540 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 19635904 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 20427526 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 5.98e-13 | 13 | 95 | 6 | 18726328 | |
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 19706714 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 18572754 | ||
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 15723075 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 14983024 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 22815848 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 22095711 | ||
| Pubmed | Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. | 1.04e-12 | 14 | 95 | 6 | 18981154 | |
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 1442307 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 19620305 | ||
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 1.04e-12 | 14 | 95 | 6 | 7526537 | |
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 19559726 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 25972534 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 15240719 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 7583919 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 16418394 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 18272764 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 2987811 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 11884139 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 19004943 | ||
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 21172865 | ||
| Pubmed | Differential constitutive expression of interferon genes in early mouse embryos. | 1.04e-12 | 14 | 95 | 6 | 7654369 | |
| Pubmed | 1.04e-12 | 14 | 95 | 6 | 2552026 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 1.04e-12 | 14 | 95 | 6 | 15254193 | |
| Interaction | IFNA7 interactions | 5.76e-06 | 9 | 84 | 3 | int:IFNA7 | |
| Interaction | IFNA13 interactions | 1.13e-05 | 11 | 84 | 3 | int:IFNA13 | |
| Interaction | IFNA1 interactions | 3.76e-05 | 16 | 84 | 3 | int:IFNA1 | |
| Cytoband | 9p22 | 1.15e-11 | 25 | 95 | 6 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 2.45e-07 | 124 | 95 | 6 | chr9p21 | |
| Cytoband | 11p15.4 | 3.99e-06 | 200 | 95 | 6 | 11p15.4 | |
| Cytoband | 1q44 | 8.40e-05 | 110 | 95 | 4 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 1.51e-04 | 128 | 95 | 4 | chr1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.77e-04 | 564 | 95 | 7 | chr11p15 | |
| Cytoband | 3p21.3 | 2.57e-04 | 59 | 95 | 3 | 3p21.3 | |
| Cytoband | 4q13 | 4.37e-04 | 15 | 95 | 2 | 4q13 | |
| Cytoband | 2q37 | 1.89e-03 | 31 | 95 | 2 | 2q37 | |
| Cytoband | Xp11.4 | 2.28e-03 | 34 | 95 | 2 | Xp11.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 4.29e-03 | 316 | 95 | 4 | chr3p21 | |
| Cytoband | 14q23.1 | 4.31e-03 | 47 | 95 | 2 | 14q23.1 | |
| Cytoband | 15q15.1 | 4.31e-03 | 47 | 95 | 2 | 15q15.1 | |
| GeneFamily | Interferons | 2.69e-09 | 32 | 72 | 6 | 598 | |
| GeneFamily | Olfactory receptors, family 2 | 5.82e-06 | 113 | 72 | 6 | 149 | |
| GeneFamily | Histatins and statherin | 4.68e-05 | 3 | 72 | 2 | 971 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 2.64e-04 | 78 | 72 | 4 | 262 | |
| GeneFamily | Olfactory receptors, family 51 | 7.13e-04 | 44 | 72 | 3 | 164 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.78e-03 | 26 | 72 | 2 | 253 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 3.98e-10 | 80 | 92 | 8 | MM646 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 7.05e-10 | 29 | 92 | 6 | MM586 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 4.71e-09 | 39 | 92 | 6 | M41095 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 2.42e-08 | 87 | 92 | 7 | MM652 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 3.87e-07 | 80 | 92 | 6 | MM1229 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 4.08e-07 | 131 | 92 | 7 | MM1127 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 5.55e-07 | 85 | 92 | 6 | MM684 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 2.34e-06 | 27 | 92 | 4 | M40935 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.01e-06 | 338 | 92 | 9 | MM17064 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.39e-06 | 343 | 92 | 9 | M5883 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 6.08e-06 | 34 | 92 | 4 | M41094 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 CSPG5 CXCL13 CCL26 IFNA4 IFNA7 PLXNB1 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 1.05e-05 | 738 | 92 | 12 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 CSPG5 CXCL13 CCL26 IFNA4 IFNA7 PLXNB1 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 1.25e-05 | 751 | 92 | 12 | M5885 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 2.27e-05 | 16 | 92 | 3 | M40964 | |
| Coexpression | NABA_MATRISOME | PCSK5 CSPG5 CXCL13 SMOC1 CCL26 IFNA4 IFNA7 PLXNB1 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 4.99e-05 | 1008 | 92 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | PCSK5 CSPG5 CXCL13 SMOC1 CCL26 IFNA4 IFNA7 PLXNB1 IFNA10 IFNA16 IL9 IFNA17 IFNA21 | 5.97e-05 | 1026 | 92 | 13 | M5889 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 9.90e-05 | 210 | 92 | 6 | MM751 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 1.93e-04 | 32 | 92 | 3 | M40934 | |
| Drug | Yfrkd | 9.04e-09 | 7 | 93 | 4 | CID000129984 | |
| Drug | Chebi:36708 | 1.80e-08 | 8 | 93 | 4 | CID011966289 | |
| Drug | 1hiv | 1.80e-08 | 8 | 93 | 4 | CID005479205 | |
| Drug | pipobroman | 5.38e-08 | 10 | 93 | 4 | CID000004842 | |
| Drug | flesinoxan | 8.42e-08 | 11 | 93 | 4 | CID000057347 | |
| Drug | R 842 | 1.81e-07 | 13 | 93 | 4 | CID000130714 | |
| Drug | AC1O52EF | 1.81e-07 | 13 | 93 | 4 | CID006450817 | |
| Drug | Lanicemine | 2.53e-07 | 14 | 93 | 4 | CID003038485 | |
| Drug | gunacin | 2.53e-07 | 14 | 93 | 4 | CID000198547 | |
| Drug | barium iodide | 2.63e-07 | 4 | 93 | 3 | CID000083684 | |
| Drug | pppA2'-5'A2'-5'A | 3.44e-07 | 15 | 93 | 4 | CID000125229 | |
| Drug | 2',3'-dideoxycytidine diphosphate | 5.84e-07 | 74 | 93 | 6 | CID000128494 | |
| Drug | YNK01 | 5.96e-07 | 17 | 93 | 4 | CID000084071 | |
| Drug | B132 | 6.56e-07 | 5 | 93 | 3 | CID002734031 | |
| Drug | p203 | 7.64e-07 | 18 | 93 | 4 | CID000019228 | |
| Drug | podophyllin | 7.64e-07 | 18 | 93 | 4 | CID011979494 | |
| Drug | Nyco | 7.64e-07 | 18 | 93 | 4 | CID000071618 | |
| Drug | Ciluprevir [USAN] | 1.20e-06 | 20 | 93 | 4 | CID006450803 | |
| Drug | val-mCyd | 1.20e-06 | 20 | 93 | 4 | CID006918726 | |
| Drug | HCV-371 | 1.31e-06 | 6 | 93 | 3 | CID003013096 | |
| Drug | L DO | 1.48e-06 | 21 | 93 | 4 | CID000097725 | |
| Drug | formosanin C | 1.80e-06 | 22 | 93 | 4 | CID000073597 | |
| Drug | Hiltonol | 2.18e-06 | 23 | 93 | 4 | CID000431963 | |
| Drug | bropirimine | 2.28e-06 | 52 | 93 | 5 | CID000065457 | |
| Drug | AC1L1ZCT | 2.60e-06 | 24 | 93 | 4 | CID000038235 | |
| Drug | cycloferon | 2.60e-06 | 24 | 93 | 4 | CID000038072 | |
| Drug | hycanthone | 3.09e-06 | 25 | 93 | 4 | CID000003634 | |
| Drug | LB80380 | 3.09e-06 | 25 | 93 | 4 | CID006480442 | |
| Drug | Beryllium | 3.31e-06 | 56 | 93 | 5 | CID000107649 | |
| Drug | ABMP | 3.64e-06 | 26 | 93 | 4 | CID000080567 | |
| Drug | AC1LAD6M | 3.64e-06 | 8 | 93 | 3 | CID000511663 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 3.64e-06 | 8 | 93 | 3 | CID010011375 | |
| Drug | VX-497 | 4.26e-06 | 27 | 93 | 4 | CID000153241 | |
| Drug | inosiplex | 4.26e-06 | 27 | 93 | 4 | CID000037510 | |
| Drug | morphine hydrochloride | UGT1A1 CACNA1E ADRB1 CSPG5 CCR9 CACNA1H GABBR2 IFNA4 IFNA7 IFNA10 IFNA17 | 4.28e-06 | 481 | 93 | 11 | CID000004253 |
| Drug | AC1NRD2B | 4.95e-06 | 28 | 93 | 4 | CID005289317 | |
| Drug | Telaprevir | 5.44e-06 | 9 | 93 | 3 | CID003010818 | |
| Drug | boceprevir | 5.44e-06 | 9 | 93 | 3 | CID010324367 | |
| Drug | NSC141633 | 5.73e-06 | 29 | 93 | 4 | CID000003628 | |
| Drug | NM 108 | 5.73e-06 | 29 | 93 | 4 | CID000500901 | |
| Drug | poly rI:rC | 6.59e-06 | 30 | 93 | 4 | CID011979660 | |
| Drug | penciclovir | 6.59e-06 | 30 | 93 | 4 | CID000004725 | |
| Drug | DZNep | 6.59e-06 | 30 | 93 | 4 | CID000073087 | |
| Drug | ridostin | 8.16e-06 | 116 | 93 | 6 | CID011979623 | |
| Drug | CHEMBL466993 | 8.59e-06 | 32 | 93 | 4 | CID005320808 | |
| Drug | 1k1n | 9.86e-06 | 182 | 93 | 7 | CID000177837 | |
| Drug | SC-57099B | 1.06e-05 | 11 | 93 | 3 | CID000178079 | |
| Drug | tenofovir disoproxil fumarate | 1.10e-05 | 34 | 93 | 4 | CID005481350 | |
| Drug | carprofen | 1.10e-05 | 34 | 93 | 4 | CID000002581 | |
| Drug | oxymatrine | 1.10e-05 | 34 | 93 | 4 | CID000114850 | |
| Drug | tilorone | 1.24e-05 | 35 | 93 | 4 | CID000005475 | |
| Drug | lobucavir | 1.24e-05 | 35 | 93 | 4 | CID000060786 | |
| Drug | temozolomide | 1.37e-05 | 127 | 93 | 6 | CID000005394 | |
| Drug | MCNU | 1.39e-05 | 36 | 93 | 4 | CID000071741 | |
| Drug | A809128 | 1.39e-05 | 36 | 93 | 4 | CID003392279 | |
| Drug | casopitant | 1.41e-05 | 12 | 93 | 3 | CID009917021 | |
| Drug | pyran | 1.55e-05 | 37 | 93 | 4 | CID000033703 | |
| Drug | FMAU | 1.55e-05 | 37 | 93 | 4 | CID000072327 | |
| Drug | anagrelide | 1.73e-05 | 38 | 93 | 4 | CID000002182 | |
| Drug | fotemustine | 1.73e-05 | 38 | 93 | 4 | CID000104799 | |
| Drug | isofagomine lactam | 1.92e-05 | 39 | 93 | 4 | CID000448980 | |
| Drug | AC1L9FQV | 2.17e-05 | 82 | 93 | 5 | CID000444118 | |
| Drug | 1 ind | 2.59e-05 | 42 | 93 | 4 | CID003037877 | |
| Drug | Sesquimustard | 2.85e-05 | 43 | 93 | 4 | CID000019092 | |
| Drug | Murabutida | 2.85e-05 | 43 | 93 | 4 | CID005362018 | |
| Drug | AC1NRBRB | 2.85e-05 | 43 | 93 | 4 | CID005288597 | |
| Drug | NSC 312887 | 2.85e-05 | 43 | 93 | 4 | CID000003368 | |
| Drug | 2-chloro-3'-deoxyadenosine | 3.12e-05 | 44 | 93 | 4 | CID003034808 | |
| Drug | axitinib | 3.42e-05 | 45 | 93 | 4 | CID006450551 | |
| Drug | Solvent Yellow-?14 | 3.73e-05 | 46 | 93 | 4 | CID005354458 | |
| Drug | AC1L9AL3 | 3.73e-05 | 46 | 93 | 4 | CID000441122 | |
| Drug | entecavir | 4.07e-05 | 47 | 93 | 4 | CID000153941 | |
| Drug | amantadine | 4.42e-05 | 95 | 93 | 5 | CID000002130 | |
| Drug | NSC289637 | 4.42e-05 | 48 | 93 | 4 | CID000004213 | |
| Drug | adefovir dipivoxil | 4.80e-05 | 49 | 93 | 4 | CID000060871 | |
| Drug | D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 | 4.80e-05 | 49 | 93 | 4 | CID000365716 | |
| Drug | busulfan | 4.89e-05 | 97 | 93 | 5 | CID000002478 | |
| Drug | trifluorothymidine | 5.63e-05 | 51 | 93 | 4 | CID000006256 | |
| Drug | TISCH | 5.63e-05 | 51 | 93 | 4 | CID000125486 | |
| Drug | PKR inhibitor | 6.08e-05 | 52 | 93 | 4 | CID006490494 | |
| Drug | famciclovir | 6.08e-05 | 52 | 93 | 4 | CID000003324 | |
| Drug | Ampligen | 6.55e-05 | 53 | 93 | 4 | CID000038077 | |
| Drug | 2-hydroxyisovaleric acid | 8.14e-05 | 56 | 93 | 4 | CID000099823 | |
| Drug | m IU | 8.14e-05 | 56 | 93 | 4 | CID006852123 | |
| Drug | Halt | 8.32e-05 | 21 | 93 | 3 | CID000094635 | |
| Drug | Lps2 | 9.35e-05 | 58 | 93 | 4 | CID000454710 | |
| Drug | Amiodarone | 9.85e-05 | 4 | 93 | 2 | DB01118 | |
| Drug | rosuvastatin | 1.00e-04 | 59 | 93 | 4 | CID000446157 | |
| Drug | AC1L1U53 | 1.07e-04 | 60 | 93 | 4 | CID000060907 | |
| Drug | hydralazine | 1.16e-04 | 186 | 93 | 6 | CID000003637 | |
| Drug | NSC-163039 | 1.30e-04 | 190 | 93 | 6 | CID000005064 | |
| Drug | azathioprine | 1.34e-04 | 120 | 93 | 5 | CID000002265 | |
| Drug | sunitinib malate | 1.37e-04 | 64 | 93 | 4 | CID006456015 | |
| Drug | adefovir | 1.37e-04 | 64 | 93 | 4 | CID000060172 | |
| Drug | AC1L1HZP | 1.37e-04 | 64 | 93 | 4 | CID000004361 | |
| Drug | HMPV | 1.42e-04 | 25 | 93 | 3 | CID004444603 | |
| Drug | EN-1530 | 1.45e-04 | 278 | 93 | 7 | CID000004425 | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; PC3; HT_HG-U133A | 1.50e-04 | 195 | 93 | 6 | 4614_DN | |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; HL60; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 2710_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 5091_DN | |
| Disease | Carcinoma, Small Cell | 2.91e-04 | 9 | 85 | 2 | C0262584 | |
| Disease | response to fenofibrate | 4.10e-04 | 50 | 85 | 3 | GO_1901557 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 8.40e-04 | 15 | 85 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | progression free survival, ovarian carcinoma | 1.22e-03 | 18 | 85 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.36e-03 | 19 | 85 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 1.36e-03 | 19 | 85 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | Lung diseases | 1.50e-03 | 78 | 85 | 3 | C0024115 | |
| Disease | Intellectual Disability | 1.87e-03 | 447 | 85 | 6 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSLIFLMSLLMAVIA | 271 | Q8WWZ7 | |
| LMSLLMAVIATASLL | 276 | Q8WWZ7 | |
| LAIFFSMALVMSLLV | 431 | Q9GZZ6 | |
| FIMSLASADLVMGLL | 96 | P08588 | |
| DMMSDLTRNDLDTLL | 676 | Q92556 | |
| VGSAALVLLLLFMMT | 426 | O95196 | |
| LMSSMKSIISLLFLL | 596 | Q15878 | |
| FSQMTKMLDLLEDFL | 1046 | Q8TDI0 | |
| LMLMSVLTCLFESLN | 121 | Q9P299 | |
| EFLKEAMSAALDLTM | 2241 | Q7Z2Y8 | |
| MFSTLLGEMDLLTQS | 11 | Q7Z5R6 | |
| IQLSFMDTAALLFMI | 441 | Q9H221 | |
| LMQALVLFTLDSLDM | 266 | Q6ZPD9 | |
| MALLTLGINSAMVLD | 126 | Q9NZ32 | |
| LDEMMDLSDLPTSLF | 36 | Q9UKA8 | |
| SEMSSLLEMLLEQRS | 1111 | Q9NPG4 | |
| MALSFSLLMAVLVLS | 1 | P01566 | |
| MFLALTMGSAEDLLL | 101 | A6NM03 | |
| AELLSMLDMGTLFTF | 611 | O95461 | |
| DLLAALTLMPLAMLS | 86 | Q9BZJ8 | |
| TLSMHASMFVSLLIL | 96 | Q96P67 | |
| LMALAEATVALAEML | 331 | P46199 | |
| LALLDEMMSDLTTLV | 261 | Q8NHP7 | |
| LFDSTLTAFLMMGNL | 381 | Q658Y4 | |
| MALSFSLLMAVLVLS | 1 | P01568 | |
| FITSSMMLVLLLGAA | 1746 | Q92824 | |
| DLMTEMTDLTSDLLG | 1546 | O43157 | |
| FLLSQLSLMDLMLIC | 61 | Q96R28 | |
| VLGIFSLALMENISM | 31 | Q96R27 | |
| FLLSQLSLMDLMLIC | 61 | Q96R27 | |
| FLLSQLSLMDLMLIC | 61 | Q8NG81 | |
| FLSMLALTDLCMGLS | 71 | Q9H2C8 | |
| FSLDVDAMITAALRM | 616 | Q9HCR9 | |
| SSALMLTMEDLLQAA | 941 | Q13608 | |
| MARSFSLLMVVLVLS | 1 | P01567 | |
| MINLAMSDLLFVFTL | 56 | P43657 | |
| SMLAMSDLGLSLSSL | 66 | Q8NGJ7 | |
| SMLAMSDLGLSLSSL | 66 | Q8NGJ6 | |
| MDTVTMKALALLADL | 206 | Q96P69 | |
| MLLAMVLTSALLLCS | 1 | P15248 | |
| MKFISTSLLLMLLVS | 1 | O43927 | |
| LSTSLMQMLLDSELK | 666 | Q8TAG9 | |
| SCTDTDIIELMMLLS | 186 | A6NCV1 | |
| FLLSQLSLMDLMHVS | 61 | Q8NHA4 | |
| DVFALLTAMMLLATL | 61 | Q7RTS6 | |
| LSRFDLLFIMLDQMD | 476 | P25205 | |
| SLMEMTEAALLLLSR | 306 | P10696 | |
| LLDTDMLMSEFSDTL | 271 | Q9HAP2 | |
| MLLLVLFAFSLMLVE | 6 | Q7Z4J2 | |
| TMTDMFLLNLAIADL | 81 | P51686 | |
| VLSANMITSLLAMDA | 446 | Q9NSG2 | |
| FALILALMLSMTGAD | 6 | P15516 | |
| SALTILGMIMASAFL | 486 | O75899 | |
| ASLAFADMLLAVLNM | 121 | Q9BZJ6 | |
| SISICDNLSELLMAM | 316 | Q8IYX8 | |
| MKSLLFTLAVFMLLA | 1 | Q9BYW3 | |
| LGMMIDLSYASDTLI | 261 | Q9H4B8 | |
| LALVLSQLMDGFSML | 391 | Q92902 | |
| VFTSMFALEMLLKLL | 831 | O95180 | |
| MDDFISISLLSLAML | 1 | Q9NUM3 | |
| FALVLALMISMISAD | 6 | P15515 | |
| LMSLAFSFLMTEALL | 51 | O14569 | |
| MALSFSLLMAVLVLS | 1 | P01571 | |
| IIANMEDSLMLLGSL | 1581 | Q8TE73 | |
| SMVDLLEGTLYSMDL | 121 | Q68BL7 | |
| LLSQLSLMDLMYIST | 61 | Q8N349 | |
| LSMLAMTDLILSTAG | 71 | Q8NGJ2 | |
| FIIIMDMLQDSSLLA | 821 | P42345 | |
| LMTALASGEISSLLM | 246 | Q8NET4 | |
| GLTLLLMAVVSMFTL | 721 | Q16799 | |
| AERLDILMSLVLSYM | 311 | Q9NYV6 | |
| FTLSLAMFLLLIFSM | 191 | Q9NYV8 | |
| TLEEFDRLSFDMILM | 61 | O14717 | |
| TLLMAASSMDDLLAI | 16 | A6NJY1 | |
| MALSFSLLMAVLVLS | 1 | P05015 | |
| EDFMILLLSITVMSD | 121 | A6NMZ2 | |
| STTDHMDSMLLLETL | 241 | Q9Y448 | |
| MIAALMSDLDSIFNS | 371 | P53794 | |
| YKLSDTVSMLDMLLS | 611 | O15457 | |
| MALSFSLLMAVLVLS | 1 | P05014 | |
| MMGLSLASAVLLASL | 1 | Q9Y258 | |
| TMIMLFSGDLDSLLN | 376 | Q9UPY5 | |
| MSLDTISLDSMILEE | 1111 | A0JNW5 | |
| MEFITSLLDALTTDM | 321 | Q9H4F8 | |
| ASRMLLVSFLLDMAV | 61 | A0A1B0GVZ9 | |
| LVSFLLDMAVRAMTS | 66 | A0A1B0GVZ9 | |
| MGSSSFLVLMVSLVL | 1 | Q8WWY7 | |
| DDTLALLNLACMMTI | 106 | Q9BSA9 | |
| MLFESADVSMLRLLE | 221 | Q5GH72 | |
| AMLAMLDLLASVGSV | 851 | Q8IZQ1 | |
| AVMLAALMSSLTSIF | 371 | A0PJK1 | |
| LMASLAESSFDVMLT | 136 | P22309 | |
| SMLLLERLMISSDAF | 1061 | Q9NW08 | |
| MAELTALESLIEMGF | 1 | Q04323 | |
| LAASFSMLSLLVIMG | 6 | Q00604 | |
| MTDALHMLTDLSAII | 141 | O14863 | |
| DLSMLFAFISLLVML | 146 | Q9HBM0 | |
| MASEEASLRALESLM | 1 | Q96QU8 | |
| LLSIISLANTLMSMT | 891 | Q9Y4E6 | |
| LFEETMGIDTMLRSL | 971 | O75132 |